Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 3, 2023Hepatology Research

Coincidental items in the definition of metabolic dysfunction‐associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver

View Full Paper
Ask AI
Bookmark
Share

Key result

Having two or more complicating factors in the MAFLD definition was associated with a higher prevalence of progressive MAFLD (32-44%) and had a 97.4% negative predictive value for UpMAFLD.

Why the study?

The authors aimed to establish a method to identify patients with fatty liver who are at high risk for a progressive phenotype.

Does the presence of multiple criteria in the definition of metabolic dysfunction-associated fatty liver identify patients at high risk for significant fibrosis?

Comparison

Patients classified by number of MAFLD definition criteria

Design

Two-cohort study

Authors

KKKeisuke KakisakaIwate Medical UniversityHKHidekatsu KurodaIwate Medical UniversityTATamami AbeIwate Medical University

Discussion

Loading...

Member takes

Overview

May aid noninvasive risk stratification in MAFLD; leaves open whether it improves outcomes before prospective validation.

Study Design

Type

Cohort (n=401)

Structured PICO

Does the presence of multiple criteria in the definition of metabolic dysfunction-associated fatty liver identify patients at high risk for significant fibrosis?

P
Population
401 patients with fatty liver, comprising 168 who underwent liver biopsy and 233 who underwent abdominal ultrasound screening.
E
Exposure
Assessment of metabolic dysfunction-associated fatty liver (MAFLD) definition criteria (body mass index of ≥23, diabetes mellitus, and coexistence of two or more metabolic risk items).
O
Outcome
Progressive phenotype of MAFLD (defined as significant fibrosis complicated with either nonalcoholic fatty liver disease activity score ≥4 [BpMAFLD] or steatosis grade ≥2 by ultrasound examination [UpMAFLD]).surrogate

Having two or more complicating factors in the MAFLD definition provides a high negative predictive value, helping to identify which patients require further evaluation for liver fibrosis.

Cite This Study

Kakisaka et al. (2023) conducted a cohort in Metabolic dysfunction-associated fatty liver (MAFLD) (n=401). Two or more complicating factors in the MAFLD definition vs. Fewer than two complicating factors was evaluated on Progressive phenotype of MAFLD (BpMAFLD or UpMAFLD). Having two or more complicating factors in the MAFLD definition was associated with a higher prevalence of progressive MAFLD (32-44%) and had a 97.4% negative predictive value for UpMAFLD.

synapsesocial.com/papers/6a9a204c41a08ee6cc4e2626https://doi.org/10.1111/hepr.13928
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis2022 · 28 citations
  2. 2Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ2010 · 1,257 citations
  3. 3Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis2021 · 39 citations
  4. 4FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study2020 · 802 citations